VACCINE NAME | AGE AT 1st DOSE | AGE AT 2nd DOSE | AGE AT 3rd DOSE | AGE AT 4th DOSE |
Hepatitis B (HepB) | B | 1 - 2 m | 6 - 18 m |
|
Rotavirus (RV) RV1 (2 dose series); RV5 (3 dose series) | 2 months | 4 months | 6 months |
|
Diphtheria, tetanus, & acellular pertussis (DTaP: <7 years) | 2 months | 4 months | 6 months | 15 - 18 months |
Tetanus, diphtheria, & acellular pertussis (Tdap: >7 years) | Tdap 11 - 12 years |
|
|
|
Haemophilus influenzae type b5 (Hib) | 2 months | 4 months | 6 months | 12-15 months |
Pneumococcal conjugate (PCV13) | 2 months | 4 months | 6 months | 12 - 15 months |
Inactivated poliovirus (IPV: <18 years) | 2 months | 4 months | 6 - 18 months | 4 - 6 years |
Influenza (ILV; LAIV) 2 doses for some | 6 - 18 months annual vaccination (IIV only) 1 or 2 doses | 2 - 8 years annual vaccination (LAIV or IIV) 1 or 2 doses | 8 - 18 years annual vaccination (LAIV or IIV) 1 dose only |
|
Measles, Mumps, Rubella (MMR) | 12 - 15 months | 4 - 6 years |
|
|
Varicella (VAR) | 12 - 15 months | 4 - 6 years |
|
|
Hepatitis A (HepA) | 12 - 18 months (2 dose series) |
|
|
|
Human papillomavirus (HPV2: females only; HPV4: males and females) | 11 - 12 years (3 dose series) |
|
|
|
Meningococcal (Hib-MenCY > 6 weeks, MenACWY-D > 9 months; MenACWY-CRM > 2 month) | 11 - 12 years |
|
|
|